Connective tissue growth factor (CTGF): A key factor in the onset and progression of kidney damage;El factor de crecimiento de tejido conectivo (CTGF): Factor clave en el inicio y la progresión del dano renal

Nefrologia

Volumn 29, Issue 5, 2009, Pages 382-391

  Sanchez Lopez E ^a   Díez, R Rodrigues ^a   Vita, J Rodríguez ^a   Mateos, S Rayego ^a   Díez, R R Rodrigues ^a   García, E Rodríguez ^a   Barria, C Lavoz ^a   Mezzano, S ^b   Selgas, R ^c   Egido, J ^a   Ortiz, A ^d   Ruiz Ortega, M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Jimenez Diaz Foundation   (Spain)

Author keywords

CTGF; Fibrosis; Inflammation; Kidney disease

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

DISEASE COURSE; HUMAN; KIDNEY DISEASE; PHYSIOLOGY; REVIEW;

CONNECTIVE TISSUE GROWTH FACTOR; DISEASE PROGRESSION; HUMANS; KIDNEY DISEASES;

EID: 72949121314     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/NEFROLOGIA.2009.29.5.5429.EN.FULL     Document Type: Review

References (93)

1. Gupta S, Clarkson MR, Duggan J, Brady HR. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 2000;58(4):1389-99.
2. Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999;248(1):44-57.
3. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004;363:62-4.
4. Yokoi H, Mukoyama M, Sugawara A, Mori K, Nagae T, Makino H, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 2002;282(5):F933-42.
5. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-61.
6. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114:1285-94.
7. Brigstock DR. The connective tissue growth factor/cysteine -rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999;20:189-206.
8. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 2001;54:57-79.
9. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993;327:125-30.
10. Albiston AL, Herington AC: Cloning and characterization of the growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3) in the rat. Biochem Biophys Res Commun 1990;166:892-7.
11. Binkert C, Landwehr J, Mary JL, Schwander J, Heinrich G. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J 1989;8:2497-502.
12. Brinkman A, Groffen C, Kortleve DJ, Geurts van Kessel A, Drop SL. Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1). EMBO J 1988;7:2417-23.
13. Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989;264:19514-27.
14. Holt GD, Pangburn MK, Ginsburg V. Properdin binds to sulfatide [Gal(3-SO4)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates. J Biol Chem 1990;265:2852-5.
15. Hoshijima M, Hattori T, Inoue M, Araki D, Hanagata H, Miyauchi A, et al. CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin ·5,1, FEBS Lett 2006;580:1376-82.
16. Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphaVbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999;19:2958-66.
17. Chen G, Grotendorst G, Eichholtz T, Khalil N. GM-CSF increases airway smooth muscle cell connective tissue expression by inducing TGF-beta receptors. Am J Physiol Lung Cell Mol Physiol 2003;284(3):L548-56.
18. Hoshijima M, Hattori T, Inoue M, Araki D, Hanagata H, Miyauchi A, et al. CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin ·5,1, FEBS Lett 2006;580:1376-82.
19. Liu X, Luo F, Pan K, Wu W, Chen H. High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells. BMC Cell Biol 2007;16;8:1.
20. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999;274(9):5830-4.
21. Park SK, Kim J, Seomun Y, Choi J, Kim DH, Han IO, Lee EH, et al. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun 2001;284(4):966-71.
22. Rimon E, Chen B, Shanks AL, Nelson DM, Sadovsky Y. Hypoxia in human trophoblasts stimulates the expression and secretion of connective tissue growth factor. Endocrinology 2008.
23. Rishikof DC, Ricupero DA, Kuang PP, Liu H, Goldstein RH. Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts. J Cell Biochem 2002;85(3):496-504.
24. Zhou G, Li C, Cai L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor betaindependent pathway. Am J Pathol 2004;165(6):2033-43.
25. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal, and scleroderma fibroblast. J Biol Chem 2000;275:1520-5.
26. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, et al. Connective tissue growth factor mediates transforming growth factor beta induced collagen synthesis: downregulation by cAMP. FASEB J 1999;13:1774-86.
27. Fu M, Zhang J, Zhu X, Myles DE, Willson TM, Liu X, et al. Peroxisome proliferators activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with smad3. J Biol Chem 2001;276:45888-94.
28. Wang W, Liu F, Chen N. Peroxisome proliferator-activated receptorgamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediators Inflamm 2007;62641.
29. Sánchez-López E, Rodríguez-Vita J, Cartier C, Rupérez M, Esteban V, Carvajal G, et al. Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Am J Physiol Renal Physiol 2008;294(1):F149-60.
30. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A.CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 2002;62(4):1149-59.
31. Iwanciw D, Rehm M, Porst M, Goppelt-Struebe M. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arterioscler. Thromb Vasc Biol 2003;23:1782-7.
32. Lee CI, Guh JY, Chen HC, Lin KH, Yang YL, Hung WC, et al. Leptin and connective tissue growth factor in advanced glycation endproduct-induced effects in NRK-49F cells. J Cell Biochem 2004;93(5):940-50.
33. Wahab NA, Weston BS, Mason RM. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. Exp Cell Res 2005;307(2):305-14.
34. Rodríguez-Vita J, Sánchez-López E, Esteban V, Rupérez M, Egido J, Ruiz-Ortega M. Angiotensin II Activates The Smad Pathway In Vascular Smooth Muscle Cells. Potential role in vascular fibrosis. Circulation 2005;111:2509-17.
35. Heusinger-Ribeiro J, Eberlein M, Wahab NA, Goppelt-Struebe M. Expression of connective tissue growth factor in human renal fibroblast: Regulatory roles of RhoA and cAMP. J Am Soc Nephrol 2001;12:1853-1.
36. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A.CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 2002;62(4):1149-59.
37. Phanish MK, Wahab NA, Hendry BM, Dockrell ME. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. Nephron Exp Nephrol 2005;100:e156-e165.
38. Wickert L, Chatain N, Kruschinsky K, Gressner AM. Glucocorticoids activate TGF-beta induced PAI-1 and CTGF expression in rat hepatocytes. Comp Hepatol 2007;2;6:5.
39. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, et al. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2003;28(6):754-61.
40. Rodrigues-Díez R, Carvajal-González G, Sánchez-López E, Rodríguez-Vita J, Díez RR, Selgas R, et al. Pharmacological modulation of epithelial mesenchymal transition caused by Angiotensin II. Role of ROCK and MAPK pathways. Pharmaceutical Research 2008;25(10):2447-61.
41. Rupérez M, Rodríguez-Díez R, Blanco-Colio LM, Sánchez-López E, Rodríguez-Vita J, Esteban V, et al. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/Rock and MAPK pathway. Hypertension 2007;50:377-83.
42. Ruperez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J, Ruiz-Ortega M. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 2003;108(12):1499-505.
43. Liu B, Yu J, Taylor L, Zhou X, Polgar P. Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts. J Cell Biochem 2006;97:1104-20.
44. Border WA, Noble NA. Transforming growth factor-b in tissue fibrosis. N Engl J Med 1994;331:1286-92.
45. Nishida T, Nakanishi T, Shimo T, Asano M, Hattori T, Tamatani T, et al. Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem Biophys Res Commun 1998;247:905-9.
46. Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR III, Carmichael DF. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 2001;276:40659-67.
47. Chen CC, Chen N, Lau LF. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblast. J Biol Chem 2001;276:10443-52.
48. Gao R, Brigstock DR. Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor. Gastroenterology 2005;129(3):1019-30.
49. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 1999;274:24321-7.
50. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. Connective tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-beta. Nat Cell Biol 2000;275:15220-5.
51. Hoshijima M, Hattori T, Inoue M, Araki D, Hanagata H, Miyauchi A, et al. CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin ·5,1, FEBS Lett 2006;580:1376-82.
52. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 1997;94:12981-6.
53. Crean JK, Finlay D, Murphy M, Moss C, Godson C, Martin F, Brady HRThe role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 2002;277(46):44187-94.
54. Matsui Y, Sadoshima J. Rapid upregulation of CTGF in cardiac myocytesby hypertrophic stimuli: implications for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol 2004;37:477-81.
55. Wahab NA, Weston BS, Roberts T, Mason RM. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol 2002;13:2437-45.
56. Szeto CC, Chow KM, Lai KB, Szeto CY, Kwan BC, Li PK. Connective tissue growth factor is responsible for transforming growth factorbeta-induced peritoneal mesothelial cell apoptosis. Nephron Exp Nephrol 2006;103(4):e166-74.
57. Wahab N, Cox D, Witherden A, Mason RM. Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1). Biochem J 2007;406:131-8.
58. Gao R, Brigstock DR. Activation of nuclear factor kappa B (NFkappaB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cells. Cell Commun Signal 2005;22;3:14.
59. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libada DE, Stepheson RC, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003;130:2779-91.
60. Nawachi K, Inoue M, Kubota S, Nishida T, Yosimichi G, Nakanishi T, et al. Tyrosine Kinase-type receptor ErbB4 in chondrocytes: interaction with connective tissue growth factor and distribution in cartilage. FEBS Lett 2002;528:109-13.
61. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001;276:10594-601.
62. Hlubocka Z, Umnerova V, Heller S, et al. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factormarkers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. J Hum Hypertens 2002;16(8):557-62.
63. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992;19(6 Pt 2):753-7.
64. Peifley KA, Winkles JA. Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells. Biochem Biophys Res Commun 1998;242(1):202-8.
65. Luscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000;102(19):2434-40.
66. Rich S, McLaughlin VV. Endothelin receptor blockers in cardiovascular disease. Circulation 2003;108(18):2184-90.
67. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000;11:25-38.
68. Ito Y, Goldschmeding R, Bende RJ, Claessen N, Chand MA, Kleij L, et al. Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 2001;12:472-84.
69. Makino H, Mukoyama M, Sugawara A, Mori K, Suganami T, Yahata K, et al. Role of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: The effect of aspirin treatment. Clin Exp Nephrol 2003;7:33-40.
70. Rupérez M, Ruiz-Ortega M, Esteban V, Lorenzo O, Mezzano S, Plaza JJ, et al. Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 2003;163:1937-47.
71. Grainger DJ. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 2004;24:399-404.
72. Naito T, Masaki T, Nikolic-Paterson DJ, Tanji C, Yorioka N, Kohno N. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol 2004;286(2):F278-F287.
73. Carvajal G, Rodríguez-Vita J, Rodrigues-Díez R, Sánchez-López E, Rupérez M, Cartier C, et al Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 2008;74(5):585-95.
74. Roberts AB, Tian F, Byfield SD, et al. Smad3 is key to TGF-betamediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006;17:19-27.
75. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-tomesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006;17(9):2484-94.
76. Liu BC, Li MX, Zhang JD, Liu xc, Zhang XL, Phillips AO. Inhibition of integrin-linked kinase via siRNA expression plasmid attenuates connective tissue growth factor-induced human proximal tubular epithelial cells to mesenchymal transition. Am J Nephrol 2008;28(1):143-51.
77. Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 2008;19(2):133-44.
78. Zhang A, Ding G, Huang S, Wu Y, Pan X, Guan X, et al. c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells. Am J Physiol Renal Physiol 2005;288:F1118-F1124.
79. Zhang C, Meng X, Zhu Z, Yang X, Deng A. Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro. Life Sci 2004;75:367-79.
80. Frazier KS, Paredes A, Dube P, Styer E. Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation. Vet Pathol 2000;37:328-35.
81. Ruiz-Ortega M, Rupérez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 2002;12-22.
82. Wu SH, Wu XH, Lu C, Dong L, Zhou GP, Chen ZQ. Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney Int 2006;69:248-56.
83. Karger A, Fitzner B, Brock P, Sparmann G, Emmrich J, Liebe S, et al. Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cellular Signalling 2008;20:1865-72.
84. Sánchez-López E, Rayego S, Rodrigues-Díez R, Rodríguez JS, Rodrigues-Díez R, Rodríguez-Vita J, et al. CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol 2009;20:1513-26.
85. Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, et al. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J Diabetes Complications.
86. Jaffa AA, Usinger WR, McHenry MB, Jaffa MA, Lipstiz SR, Lackland D, et al. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Group. Connective Tissue Growth Factor and Susceptibility to Renal and Vascular Disease Risk in Type 1 Diabetes. J Clin Endocrinol Metab 2008;93(5):1893-900.
87. Nonaka Takahashi S, Fujita T, Takahashi T, Wada Y, Fuke Y, Satomura A, et al. TGF-beta1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy. J Nephrol 2008;21(1):53-63.
88. Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M, et al. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail 2008;10(4):373-9.
89. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 2005;67:799-812.
90. Ruiz-Ortega M, Rupérez M, Esteban V, Rodríguez-Vita J, Sánchez-López E, Carvajal G, et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006;21:16-20.
91. Okada H, Kikuta T, Kobayashi T, Inoue T, Kanno Y, Takigawa M, et al. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 2005;16:133-43.
92. Li GM, Li DG, Xie Q, Shi Y, Jiang S, Zhou HJ, et al. Effect of silencing connective tissue growth factor on rat liver fibrosis and the accumulation of extracellular matrix. Zhonghua Gan Zang Bing Za Zhi 2008;16(3):188-92.
93. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J 2007;21:3355-68.